T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.66B | |
| 2 | +$1.39B | |
| 3 | +$1.38B | |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| 1 | +$4.2B | |
| 2 | +$3.24B | |
| 3 | +$2.75B | |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| 1 | Technology | 35.67% |
| 2 | Financials | 11.77% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Urban Outfitters
URBN
$5.9B
| $27.5M | ﹤0.01% |
365,397
+131,539
|
|
||
977
Olema Pharmaceuticals
OLMA
$1.26B
| $27.4M | ﹤0.01% |
1,096,035
+1,064,254
|
|
||
978
Pricesmart
PSMT
$4.55B
| $27.3M | ﹤0.01% |
222,741
+1,246
|
|
||
979
Trimble
TRMB
$16.1B
| $27.3M | ﹤0.01% |
348,576
-2,655
|
|
||
980
Crocs
CROX
$4.04B
| $27.3M | ﹤0.01% |
318,632
+9,663
|
|
||
981
A10 Networks
ATEN
$1.48B
| $27.2M | ﹤0.01% |
1,536,628
-36,437
|
|
||
982
Hologic
HOLX
$16.8B
| $27M | ﹤0.01% |
362,673
+9,196
|
|
||
983
Planet Labs
PL
$8.68B
| $27M | ﹤0.01% |
1,369,657
-581,543
|
|
||
984
Oric Pharmaceuticals
ORIC
$1.41B
| $27M | ﹤0.01% |
3,295,122
+423,795
|
|
||
985
SoFi Technologies
SOFI
$23.6B
| $26.9M | ﹤0.01% |
1,026,149
+102,582
|
|
||
986
Viavi Solutions
VIAV
$6.96B
| $26.8M | ﹤0.01% |
1,505,528
-444,131
|
|
||
987
Rollins
ROL
$27.1B
| $26.8M | ﹤0.01% |
446,189
-126,218
|
|
||
988
Wolfspeed
WOLF
$748M
| $26.8M | ﹤0.01% |
1,536,758
+5,988
|
|
||
|
RAPP
989
Rapport Therapeutics
RAPP
$1.41B
| $26.7M | ﹤0.01% |
881,609
-220,782
|
|
||
|
BCPC
990
Balchem Corp
BCPC
$5.5B
| $26.6M | ﹤0.01% |
173,403
-65,454
|
|
||
|
MBX
991
MBX Biosciences
MBX
$1.3B
| $26.5M | ﹤0.01% |
840,506
-114,220
|
|
||
992
Wheaton Precious Metals
WPM
$67.5B
| $26.5M | ﹤0.01% |
225,569
-71,692
|
|
||
993
Principal Financial Group
PFG
$19.5B
| $26.5M | ﹤0.01% |
300,121
+5,192
|
|
||
994
Pool Corp
POOL
$7.68B
| $26.4M | ﹤0.01% |
115,450
-79,756
|
|
||
|
BCAX
995
Bicara Therapeutics
BCAX
$1.29B
| $26.2M | ﹤0.01% |
1,559,535
-195,876
|
|
||
996
ePlus
PLUS
$2.01B
| $26.1M | ﹤0.01% |
298,050
+1,267
|
|
||
997
Coca-Cola Europacific Partners
CCEP
$45.2B
| $26.1M | ﹤0.01% |
288,178
+27,411
|
|
||
998
Pharvaris
PHVS
$1.68B
| $26.1M | ﹤0.01% |
941,605
+124,797
|
|
||
999
Charter Communications
CHTR
$27.8B
| $26.1M | ﹤0.01% |
125,133
-383,551
|
|
||
1000
Eagle Materials
EXP
$6.09B
| $26.1M | ﹤0.01% |
126,196
-134,962
|
|